Detalhe da pesquisa
1.
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families.
J Pharmacol Exp Ther
; 343(3): 617-27, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22935731
2.
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families.
Bioorg Med Chem Lett
; 22(9): 3208-12, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22465635
3.
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors.
Bioorg Med Chem Lett
; 18(1): 386-90, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18023347
4.
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.
J Med Chem
; 50(7): 1584-97, 2007 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17343372
5.
Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors.
Mol Cancer Ther
; 5(4): 1007-13, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16648572
6.
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor.
Mol Cancer Ther
; 5(4): 995-1006, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16648571
7.
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors.
J Med Chem
; 48(19): 6066-83, 2005 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-16162008
8.
7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors.
J Med Chem
; 51(13): 3777-87, 2008 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18557606
9.
Thienopyridine urea inhibitors of KDR kinase.
Bioorg Med Chem Lett
; 17(5): 1246-9, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17188869
10.
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia.
Blood
; 109(8): 3400-8, 2007 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17209055
11.
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases.
Bioorg Med Chem Lett
; 16(16): 4326-30, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16735117
12.
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases.
Bioorg Med Chem Lett
; 13(11): 1897-901, 2003 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12749893
13.
A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units.
Bioorg Med Chem Lett
; 13(21): 3817-20, 2003 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-14552787
14.
Trifluoromethyl ketones as inhibitors of histone deacetylase.
Bioorg Med Chem Lett
; 12(23): 3443-7, 2002 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12419380
15.
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
Bioorg Med Chem Lett
; 12(20): 2919-23, 2002 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12270175
16.
Isoindolinone ureas: a novel class of KDR kinase inhibitors.
Bioorg Med Chem Lett
; 14(17): 4505-9, 2004 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-15357981
17.
Alpha-keto amides as inhibitors of histone deacetylase.
Bioorg Med Chem Lett
; 13(19): 3331-5, 2003 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-12951120